Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 6143 entries
Sorted by: Best Match Show Resources per page
A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Gene

Coeli-Lacchini FB, Turatti W, Elias PC, Elias LL, Martinelli CE, Moreira AC, Antonini SR, de Castro M.
PMID: 23570880
Gene. 2013 Sep 10;526(2):239-45. doi: 10.1016/j.gene.2013.03.082. Epub 2013 Apr 06.

CONTEXT: Molecular diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) has not been straightforward.OBJECTIVE: To conduct a comprehensive genetic analysis by Multiplex Ligation dependent Probe Amplification (MLPA) and evaluate its reliability for the molecular CAH-21OHD diagnosis.PATIENTS...

Cite
Coeli-Lacchini FB, Turatti W, Elias PC, et al. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Gene. 2013;526(2):239-45doi: 10.1016/j.gene.2013.03.082.
Coeli-Lacchini, F. B., Turatti, W., Elias, P. C., Elias, L. L., Martinelli, C. E., Moreira, A. C., Antonini, S. R., & de Castro, M. (2013). A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Gene, 526(2), 239-45. https://doi.org/10.1016/j.gene.2013.03.082
Coeli-Lacchini, Fernanda Borchers, et al. "A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency." Gene vol. 526,2 (2013): 239-45. doi: https://doi.org/10.1016/j.gene.2013.03.082
Coeli-Lacchini FB, Turatti W, Elias PC, Elias LL, Martinelli CE, Moreira AC, Antonini SR, de Castro M. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Gene. 2013 Sep 10;526(2):239-45. doi: 10.1016/j.gene.2013.03.082. Epub 2013 Apr 06. PMID: 23570880.
Copy Download .nbib Format: NLM
Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension.

Annals of the American Thoracic Society

Baird GL, Walsh T, Aliotta J, Allahua M, Andrew R, Bourjeily G, Brodsky AS, Denver N, Dooner M, Harrington EO, Klinger JR, MacLean MR, Mullin CJ, Pereira M, Poppas A, Whittenhall M, Ventetuolo CE.
PMID: 32885987
Ann Am Thorac Soc. 2021 Feb;18(2):218-228. doi: 10.1513/AnnalsATS.202006-671OC.

No abstract available.

Cite
Baird GL, Walsh T, Aliotta J, et al. Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2021;18(2):218-228doi: 10.1513/AnnalsATS.202006-671OC.
Baird, G. L., Walsh, T., Aliotta, J., Allahua, M., Andrew, R., Bourjeily, G., Brodsky, A. S., Denver, N., Dooner, M., Harrington, E. O., Klinger, J. R., MacLean, M. R., Mullin, C. J., Pereira, M., Poppas, A., Whittenhall, M., & Ventetuolo, C. E. (2021). Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension. Annals of the American Thoracic Society, 18(2), 218-228. https://doi.org/10.1513/AnnalsATS.202006-671OC
Baird, Grayson L, et al. "Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension." Annals of the American Thoracic Society vol. 18,2 (2021): 218-228. doi: https://doi.org/10.1513/AnnalsATS.202006-671OC
Baird GL, Walsh T, Aliotta J, Allahua M, Andrew R, Bourjeily G, Brodsky AS, Denver N, Dooner M, Harrington EO, Klinger JR, MacLean MR, Mullin CJ, Pereira M, Poppas A, Whittenhall M, Ventetuolo CE. Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2021 Feb;18(2):218-228. doi: 10.1513/AnnalsATS.202006-671OC. PMID: 32885987; PMCID: PMC7869782.
Copy Download .nbib Format: NLM
Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.

Metabolism: clinical and experimental

Ciaraldi TP, Aroda V, Mudaliar SR, Henry RR.
PMID: 23958241
Metabolism. 2013 Nov;62(11):1587-96. doi: 10.1016/j.metabol.2013.07.004. Epub 2013 Aug 17.

OBJECTIVE: Chronic low-grade inflammation is a common feature of insulin resistant states, including obesity and type 2 diabetes. Less is known about inflammation in Polycystic Ovary Syndrome (PCOS). Thus we evaluated the impact of PCOS on circulating cytokine levels...

Cite
Ciaraldi TP, Aroda V, Mudaliar SR, et al. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Metabolism. 2013;62(11):1587-96doi: 10.1016/j.metabol.2013.07.004.
Ciaraldi, T. P., Aroda, V., Mudaliar, S. R., & Henry, R. R. (2013). Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Metabolism: clinical and experimental, 62(11), 1587-96. https://doi.org/10.1016/j.metabol.2013.07.004
Ciaraldi, Theodore P, et al. "Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment." Metabolism: clinical and experimental vol. 62,11 (2013): 1587-96. doi: https://doi.org/10.1016/j.metabol.2013.07.004
Ciaraldi TP, Aroda V, Mudaliar SR, Henry RR. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Metabolism. 2013 Nov;62(11):1587-96. doi: 10.1016/j.metabol.2013.07.004. Epub 2013 Aug 17. PMID: 23958241.
Copy Download .nbib Format: NLM
Relationship between leptin receptor and polycystic ovary syndrome.

Gene

Li L, Lee KJ, Choi BC, Baek KH.
PMID: 23769971
Gene. 2013 Sep 15;527(1):71-4. doi: 10.1016/j.gene.2013.05.074. Epub 2013 Jun 13.

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, which is involved in the multi-system disease, and its etiology is still not clearly understood. It is currently considered that not only the genetic factors but also...

Cite
Li L, Lee KJ, Choi BC, et al. Relationship between leptin receptor and polycystic ovary syndrome. Gene. 2013;527(1):71-4doi: 10.1016/j.gene.2013.05.074.
Li, L., Lee, K. J., Choi, B. C., & Baek, K. H. (2013). Relationship between leptin receptor and polycystic ovary syndrome. Gene, 527(1), 71-4. https://doi.org/10.1016/j.gene.2013.05.074
Li, Lan, et al. "Relationship between leptin receptor and polycystic ovary syndrome." Gene vol. 527,1 (2013): 71-4. doi: https://doi.org/10.1016/j.gene.2013.05.074
Li L, Lee KJ, Choi BC, Baek KH. Relationship between leptin receptor and polycystic ovary syndrome. Gene. 2013 Sep 15;527(1):71-4. doi: 10.1016/j.gene.2013.05.074. Epub 2013 Jun 13. PMID: 23769971.
Copy Download .nbib Format: NLM
Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.

Fertility and sterility

Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF.
PMID: 25585504
Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10.

OBJECTIVE: To study the impact of adrenal hyperandrogenism (AH; defined as DHEAS concentration >95th percentile of a healthy female control population) on cardiometabolic risk factors associated with polycystic ovary syndrome (PCOS).DESIGN: Cross-sectional study.SETTING: Academic hospital.PATIENT(S): Two-hundred ninety-eight consecutive women...

Cite
Alpañés M, Luque-Ramírez M, Martínez-García MÁ, et al. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertil Steril. 2015;103(3):795-801.e2doi: 10.1016/j.fertnstert.2014.12.105.
Alpañés, M., Luque-Ramírez, M., Martínez-García, M. �. �., Fernández-Durán, E., Álvarez-Blasco, F., & Escobar-Morreale, H. F. (2015). Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertility and sterility, 103(3), 795-801.e2. https://doi.org/10.1016/j.fertnstert.2014.12.105
Alpañés, Macarena, et al. "Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome." Fertility and sterility vol. 103,3 (2015): 795-801.e2. doi: https://doi.org/10.1016/j.fertnstert.2014.12.105
Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10. PMID: 25585504.
Copy Download .nbib Format: NLM
PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche.

The Journal of clinical endocrinology and metabolism

Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Häkkinen M, Auriola S, Morin-Papunen L, Liimatta J.
PMID: 34060603
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3335-e3345. doi: 10.1210/clinem/dgab385.

CONTEXT: Premature adrenarche (PA) may increase the risk for polycystic ovary syndrome (PCOS).OBJECTIVE: To study features of PCOS in young adult women with a history of PA.METHODS: Thirty PA and 42 control females were followed from prepuberty to young...

Cite
Tennilä J, Jääskeläinen J, Utriainen P, et al. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche. J Clin Endocrinol Metab. 2021;106(9):e3335-e3345doi: 10.1210/clinem/dgab385.
Tennilä, J., Jääskeläinen, J., Utriainen, P., Voutilainen, R., Häkkinen, M., Auriola, S., Morin-Papunen, L., & Liimatta, J. (2021). PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche. The Journal of clinical endocrinology and metabolism, 106(9), e3335-e3345. https://doi.org/10.1210/clinem/dgab385
Tennilä, Jussi, et al. "PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche." The Journal of clinical endocrinology and metabolism vol. 106,9 (2021): e3335-e3345. doi: https://doi.org/10.1210/clinem/dgab385
Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Häkkinen M, Auriola S, Morin-Papunen L, Liimatta J. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3335-e3345. doi: 10.1210/clinem/dgab385. PMID: 34060603; PMCID: PMC8372635.
Copy Download .nbib Format: NLM
Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood.

Frontiers in endocrinology

Liimatta J, Utriainen P, Voutilainen R, Jääskeläinen J.
PMID: 30042733
Front Endocrinol (Lausanne). 2018 Jul 10;9:375. doi: 10.3389/fendo.2018.00375. eCollection 2018.

No abstract available.

Cite
Liimatta J, Utriainen P, Voutilainen R, et al. Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood. Front Endocrinol (Lausanne). 2018;9:375doi: 10.3389/fendo.2018.00375.
Liimatta, J., Utriainen, P., Voutilainen, R., & Jääskeläinen, J. (2018). Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood. Frontiers in endocrinology, 9375. https://doi.org/10.3389/fendo.2018.00375
Liimatta, Jani, et al. "Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood." Frontiers in endocrinology vol. 9 (2018): 375. doi: https://doi.org/10.3389/fendo.2018.00375
Liimatta J, Utriainen P, Voutilainen R, Jääskeläinen J. Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood. Front Endocrinol (Lausanne). 2018 Jul 10;9:375. doi: 10.3389/fendo.2018.00375. eCollection 2018. PMID: 30042733; PMCID: PMC6048846.
Copy Download .nbib Format: NLM
Relationship between leptin receptor and polycystic ovary syndrome.

Gene

Li L, Lee KJ, Choi BC, Baek KH.
PMID: 23769971
Gene. 2013 Sep 15;527(1):71-4. doi: 10.1016/j.gene.2013.05.074. Epub 2013 Jun 13.

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, which is involved in the multi-system disease, and its etiology is still not clearly understood. It is currently considered that not only the genetic factors but also...

Cite
Li L, Lee KJ, Choi BC, et al. Relationship between leptin receptor and polycystic ovary syndrome. Gene. 2013;527(1):71-4doi: 10.1016/j.gene.2013.05.074.
Li, L., Lee, K. J., Choi, B. C., & Baek, K. H. (2013). Relationship between leptin receptor and polycystic ovary syndrome. Gene, 527(1), 71-4. https://doi.org/10.1016/j.gene.2013.05.074
Li, Lan, et al. "Relationship between leptin receptor and polycystic ovary syndrome." Gene vol. 527,1 (2013): 71-4. doi: https://doi.org/10.1016/j.gene.2013.05.074
Li L, Lee KJ, Choi BC, Baek KH. Relationship between leptin receptor and polycystic ovary syndrome. Gene. 2013 Sep 15;527(1):71-4. doi: 10.1016/j.gene.2013.05.074. Epub 2013 Jun 13. PMID: 23769971.
Copy Download .nbib Format: NLM
Neuropeptidergic Control of Neurosteroids Biosynthesis.

Frontiers in neuroendocrinology

Ubuka T, Tsutsui K.
PMID: 34999057
Front Neuroendocrinol. 2022 Jan 06;100976. doi: 10.1016/j.yfrne.2021.100976. Epub 2022 Jan 06.

Neurosteroids are steroids synthesized within the central nervous system either from cholesterol or by metabolic reactions of circulating steroid hormone precursors. It has been suggested that neurosteroids exert pleiotropic activities within the central nervous system, such as organization and...

Cite
Ubuka T, Tsutsui K. Neuropeptidergic Control of Neurosteroids Biosynthesis. Front Neuroendocrinol. 2022;100976doi: 10.1016/j.yfrne.2021.100976.
Ubuka, T., & Tsutsui, K. (2022). Neuropeptidergic Control of Neurosteroids Biosynthesis. Frontiers in neuroendocrinology, 100976. https://doi.org/10.1016/j.yfrne.2021.100976
Ubuka, Takayoshi, and Tsutsui, Kazuyoshi. "Neuropeptidergic Control of Neurosteroids Biosynthesis." Frontiers in neuroendocrinology vol. (2022): 100976. doi: https://doi.org/10.1016/j.yfrne.2021.100976
Ubuka T, Tsutsui K. Neuropeptidergic Control of Neurosteroids Biosynthesis. Front Neuroendocrinol. 2022 Jan 06;100976. doi: 10.1016/j.yfrne.2021.100976. Epub 2022 Jan 06. PMID: 34999057.
Copy Download .nbib Format: NLM
Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain.

Progress in neurobiology

Patte-Mensah C, Meyer L, Taleb O, Mensah-Nyagan AG.
PMID: 23948490
Prog Neurobiol. 2014 Feb;113:70-8. doi: 10.1016/j.pneurobio.2013.07.004. Epub 2013 Aug 12.

Because the treatment and management of neuropathic pain are extremely complicated, the characterization of novel analgesics and neuroprotectors with safe toxicological profiles is a crucial need to develop efficient therapies. Several investigations revealed that the natural neurosteroid allopregnanolone (AP)...

Cite
Patte-Mensah C, Meyer L, Taleb O, et al. Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain. Prog Neurobiol. 2013;113:70-8doi: 10.1016/j.pneurobio.2013.07.004.
Patte-Mensah, C., Meyer, L., Taleb, O., & Mensah-Nyagan, A. G. (2014). Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain. Progress in neurobiology, 11370-8. https://doi.org/10.1016/j.pneurobio.2013.07.004
Patte-Mensah, C, et al. "Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain." Progress in neurobiology vol. 113 (2014): 70-8. doi: https://doi.org/10.1016/j.pneurobio.2013.07.004
Patte-Mensah C, Meyer L, Taleb O, Mensah-Nyagan AG. Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain. Prog Neurobiol. 2014 Feb;113:70-8. doi: 10.1016/j.pneurobio.2013.07.004. Epub 2013 Aug 12. PMID: 23948490.
Copy Download .nbib Format: NLM
Bisphenol A and human health: a review of the literature.

Reproductive toxicology (Elmsford, N.Y.)

Rochester JR.
PMID: 23994667
Reprod Toxicol. 2013 Dec;42:132-55. doi: 10.1016/j.reprotox.2013.08.008. Epub 2013 Aug 30.

There is growing evidence that bisphenol A (BPA) may adversely affect humans. BPA is an endocrine disruptor that has been shown to be harmful in laboratory animal studies. Until recently, there were relatively few epidemiological studies examining the relationship...

Cite
Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013;42:132-55doi: 10.1016/j.reprotox.2013.08.008.
Rochester, J. R. (2013). Bisphenol A and human health: a review of the literature. Reproductive toxicology (Elmsford, N.Y.), 42132-55. https://doi.org/10.1016/j.reprotox.2013.08.008
Rochester, Johanna R. "Bisphenol A and human health: a review of the literature." Reproductive toxicology (Elmsford, N.Y.) vol. 42 (2013): 132-55. doi: https://doi.org/10.1016/j.reprotox.2013.08.008
Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013 Dec;42:132-55. doi: 10.1016/j.reprotox.2013.08.008. Epub 2013 Aug 30. PMID: 23994667.
Copy Download .nbib Format: NLM
Beyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research.

Animals : an open access journal from MDPI

Whitham JC, Bryant JL, Miller LJ.
PMID: 32784884
Animals (Basel). 2020 Aug 09;10(8). doi: 10.3390/ani10081381.

Animal welfare researchers are committed to identifying novel measures for enhancing the quality of life of individual animals. Recently, welfare scientists have emphasized the need for tracking multiple indicators of an animal's behavioral, emotional and mental health. Researchers are...

Cite
Whitham JC, Bryant JL, Miller LJ. Beyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research. Animals (Basel). 2020;10(8)doi: 10.3390/ani10081381.
Whitham, J. C., Bryant, J. L., & Miller, L. J. (2020). Beyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research. Animals : an open access journal from MDPI, 10(8), . https://doi.org/10.3390/ani10081381
Whitham, Jessica C, et al. "Beyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research." Animals : an open access journal from MDPI vol. 10,8 (2020). doi: https://doi.org/10.3390/ani10081381
Whitham JC, Bryant JL, Miller LJ. Beyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research. Animals (Basel). 2020 Aug 09;10(8). doi: 10.3390/ani10081381. PMID: 32784884; PMCID: PMC7459918.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 6143 entries